Key Record Dates
| ClinicalTrials.gov Identifier: | NCT03875235 |
|---|---|
| Brief Title: | Durvalumab or Placebo in Combination With Gemcitabine/Cisplatin in Patients With 1st Line Advanced Biliary Tract Cancer (TOPAZ-1) (TOPAZ-1) |
| First Submitted : | March 13, 2019 |
| First Submitted that Met QC Criteria : | March 13, 2019 |
| First Posted : | March 14, 2019 |
| Results First Submitted : | August 10, 2022 |
| Results First Posted with QC Comments : | September 6, 2022 |
| Results First Submitted that Met QC Criteria : | March 21, 2023 |
| Results First Posted : | April 13, 2023 |
| Last Update Submitted that Met QC Criteria : | May 13, 2024 |
| Last Update Posted : | May 16, 2024 |